Communicable diseases — Communicable disease incidence by country

This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please...

Countries reporting
34
Highest
35,246 Cases
Brazil
Lowest
4 Cases
Iceland
Median
74.5 Cases
Years covered
45
1981–2025
Data points
1,643

What the numbers show

Communicable diseases — Communicable disease incidence is currently reported for 34 countries. The highest value is 35,246 Cases in Brazil; the lowest is 4 Cases in Iceland.

The median across all reporting countries is 74.5 Cases, and the mean is 2,812 Cases.

The gap between the highest and lowest reporting country is a factor of about 8,812.

Over the past decade 6 countries rose and 27 fell. The largest increase was in Czechia (up 96.9%), and the largest decrease in Germany (down 88.4%).

Communicable diseases — Communicable disease incidence: full country ranking

#Country LatestYear 10-year changeTrend
1 Brazil 35,246 Cases 2021 down 18.5% volatile
2 Mexico 18,895 Cases 2024 up 69.9% volatile
3 United States 17,409 Cases 2023 down 27.8% falling
4 Colombia 14,169 Cases 2025 up 90.5% rising
5 Ukraine 3,127 Cases 2024 down 68.2% falling
6 Chile 1,483 Cases 2025 up 39.0% volatile
7 Peru 1,269 Cases 2025 down 28.7% falling
8 Costa Rica 1,074 Cases 2025 up 11.1% volatile
9 France 453 Cases 2024 down 30.9% volatile
10 Italy 450 Cases 2024 down 51.7% volatile
11 Japan 332 Cases 2024 down 27.0% volatile
12 Spain 299 Cases 2023 down 65.2% volatile
13 Romania 279 Cases 2024 down 33.1% falling
14 Portugal 194 Cases 2024 down 51.3% volatile
15 United Kingdom 157 Cases 2024 down 44.3% volatile
16 Canada 84 Cases 2024 down 65.4% volatile
17 Australia 75 Cases 2012 down 69.5% volatile
18 Germany 74 Cases 2019 down 88.4% volatile
19 Bulgaria 65 Cases 2024 up 44.4% rising
20 Belgium 64 Cases 2024 down 52.9% volatile
21 Czechia 63 Cases 2024 up 96.9% volatile
22 Sweden 62 Cases 2007 down 18.4% volatile
23 Hungary 50 Cases 2024 down 2.0% volatile
24 Greece 44 Cases 2024 down 66.7% volatile
25 Austria 43 Cases 2024 down 49.4% volatile
26 Switzerland 38 Cases 2024 down 51.9% volatile
27 Denmark 27 Cases 2024 down 10.0% volatile
28 Norway 24 Cases 2024 down 46.7% volatile
29 Finland 18 Cases 2024 down 10.0% rising
30 Ireland 17 Cases 2024 down 46.9% volatile
31 Israel 16 Cases 2025 down 64.4% volatile
32 New Zealand 11 Cases 2025 down 21.4% volatile
33 Luxembourg 9 Cases 2024 down 40.0% volatile
34 Iceland 4 Cases 2024 volatile

Regions and income groups

Aggregates are excluded from the country ranking above so that a region can never outrank a country.

Share, cite or embed this page

Cite this page

Communicable diseases — Communicable disease incidence by country. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 20 August 2026, from https://health.statizoid.com/stat/communicable-diseases-communicable-disease-incidence/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/stat/communicable-diseases-communicable-disease-incidence/">Communicable diseases — Communicable disease incidence by country</a> — Statizoid

About this data

Indicator
Communicable diseases — Communicable disease incidence
Unit
Cases
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
44 places, 1,643 data points, 1981–2025
Last refreshed

This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.